The microRNA-200 family is upregulated in endometrial carcinoma.
about
Functional Role of the microRNA-200 Family in Breast Morphogenesis and NeoplasiaMiR-200, a new star miRNA in human cancermiRNA signature and Dicer requirement during human endometrial stromal decidualization in vitroEndometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.Prognostic significance of miR-205 in endometrial cancer.microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinomaExpression patterns of microRNAs in porcine endometrium and their potential roles in embryo implantation and placentationmiR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.Small non-coding RNA deregulation in endometrial carcinogenesis.Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs.MicroRNA heterogeneity in endometrial cancer cell lines revealed by deep sequencingMicroRNAs as Biomarkers in Cancer.microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer.Non-coding RNAs in Uterine Development, Function and Disease.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancerIdentification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer.MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes.Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancerTM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.The role of miRNAs in endometrial cancer.The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.Tumor-suppressing effects of miR-429 on human osteosarcoma.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B.Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
P2860
Q26861636-3EE865F3-074A-4E7C-A9D7-47FBAC3EC16FQ27004023-7D99AAB4-547F-4486-9CC2-975407364E48Q28481447-8D23EA1F-C561-486A-887B-6AD641B3ED14Q33714207-6B4741C9-6FD0-451E-99B5-557B3BEBA839Q33815178-B5C6A710-FA58-4A99-AC5C-D05AA3EE66B5Q34238901-EE706624-5FE6-4F76-8560-50EAEB5F9F4FQ34312916-0DD73AF0-3C42-400C-BB4E-44A52C602C22Q34346375-9BF200D5-5456-4632-ADD0-91C70DBCDC47Q34393036-76F637B7-9FBF-4C4D-9EC6-58328CF9F2D7Q35088272-A725BA70-A79B-4AA3-8C65-50744849B631Q35632200-496A724B-DFF5-401F-BF20-0136AC5B3258Q35741534-6BF32963-E87D-431E-B61A-9AED00E3D862Q35945406-C3BAB169-997D-4D34-B85B-927AC99D8E46Q36334541-5669D60C-8DA6-448C-9A30-7B857F00664BQ36335261-F749ECD0-C063-4A60-91B3-E768173B91F1Q36424194-78410CE7-432F-4ED2-8C36-2C737AD81EB3Q36930853-AA7B968C-C5B0-427A-B614-FAED9E02B21AQ37007297-9FD7F570-4543-4EA5-9FE2-E33F9ADBC3ABQ37093290-26EC018F-8F06-4010-9A39-173E8199740EQ37233285-B9DEF75A-F0E4-48BE-B20F-DFF038D6B67BQ37311926-61ED9A30-3270-471F-B61F-63E6D153095BQ37687451-95FE34C3-D644-493D-84B8-E89E3CD501BAQ37702543-ACFE9D93-B896-4942-A7AB-72E3620CA5BEQ37702641-BBAF4F8D-1D2E-4791-B0FF-4691ECA8666EQ37745985-256838C8-DF33-4DB3-8A2D-4FC2B7017E02Q38258014-E9D87889-0057-484C-8354-9771456CE537Q38362213-DA7A4F5E-C7D7-41C0-B434-7690355A7865Q38600963-43F5443E-41C2-46C6-960F-284C49D94EB6Q38820391-7EC6E580-61E1-4B6D-9DE2-7281E3FB9473Q38826625-3FFA48D5-1402-4BAB-AFDD-D2762D68041CQ38826865-5929EDF6-B13D-4E5E-8F16-48F2932BCCB6Q39014994-06147B2D-AF5A-483A-9427-12DEF7897057Q39317584-3FB95D04-8460-4CBC-A79B-525E75D48FE2Q39567135-25BD1F50-F8CD-4152-832A-3CCB0CEDEC13Q41371230-FAEF967F-8246-442C-BC19-4E21B48785BFQ44132305-847C0233-27E8-42B4-8FA3-2C83D2341EFEQ45888331-6F7BC542-BC72-4291-832B-FA09A82874B2Q47737163-E5713019-7724-45C2-AC8E-24444AFA58F2Q47838011-66B04912-8F54-4511-BF6A-BF9994635104Q50197957-2514805E-7368-44FF-B110-41C585B0B034
P2860
The microRNA-200 family is upregulated in endometrial carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The microRNA-200 family is upregulated in endometrial carcinoma.
@ast
The microRNA-200 family is upregulated in endometrial carcinoma.
@en
The microRNA-200 family is upregulated in endometrial carcinoma.
@nl
type
label
The microRNA-200 family is upregulated in endometrial carcinoma.
@ast
The microRNA-200 family is upregulated in endometrial carcinoma.
@en
The microRNA-200 family is upregulated in endometrial carcinoma.
@nl
prefLabel
The microRNA-200 family is upregulated in endometrial carcinoma.
@ast
The microRNA-200 family is upregulated in endometrial carcinoma.
@en
The microRNA-200 family is upregulated in endometrial carcinoma.
@nl
P2093
P2860
P1433
P1476
The microRNA-200 family is upregulated in endometrial carcinoma.
@en
P2093
Harriet Feilotter
Jaime Snowdon
Tim Childs
Victor A Tron
Xiao Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0022828
P407
P577
2011-08-29T00:00:00Z